WinstonWınston
Back
Stock

Ambu A/S

AMBFF
61
Medical - Devices · Healthcare
Price
$10.10
+0.00 (+0.00%)
Market Cap
$2.66B
Exchange
Other OTC
Winston Score
61
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Sep 5, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality
Good
Growth
Good
Cash Flow
Strong
Stability
Exceptional
Valuation
Good
Dividends
Weak

Share count rising — dilution

+5.4% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 253.2M (2021) → 267.0M (2025)

§Winston Score History

The full picture

Ambu is a Danish medical device company that makes single-use endoscopes and patient monitoring equipment. Endoscopes are small cameras doctors insert into the body to see inside airways, bladders, and other areas. Ambu pioneered the idea of disposable endoscopes, replacing traditional reusable ones that require expensive cleaning between patients.

The company earns revenue by selling its single-use devices to hospitals and clinics, creating a recurring demand since each device is thrown away after one procedure. Ambu operates globally, with major markets in North America and Europe, and has a market cap of around $2.7 billion. Its competitive moat comes from being the first mover in single-use endoscopy, holding key patents and strong brand recognition among healthcare providers. The main growth driver is expanding into new endoscope categories beyond its core pulmonary line, though the company faces ongoing pressure to prove that disposable devices can match reusable ones on both cost and clinical performance.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+8.4% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+26.1% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

kr 137M/ year

Declining (-58% vs prior year)

2.3% of revenue

Below sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

47.2%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

kr 702M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Ambu A/S is growing revenue at 8% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
59.5%
Premium pricing power — 59.5% gross margin
Profit after running costs
Operating Margin
13.5%
Healthy — 13.5% operating margin
Return on the money invested
ROCE
11.3%
Below par — 11.3% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+4.5%
Slow sales growth (+4.5% YoY)
Profit growth
EPS YoY
+41.8%
Earnings growing fast (+41.8% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
185%
Turns 185% of profit into real cash
Spare cash per sale
FCF Margin
11.8%
Modest free cash flow (11.8%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.02
Conservative — low debt load (0.02)
Covers its interest
Interest Cover
11.95x
Comfortably covers interest (11.9x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
35.6x
Pricey — P/E 35.6

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+18.1
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (35.6 → 17.5)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
0.63%
Small dividend — 0.63% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
-66.9%
Dividend cut (-66.9% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial